Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002554514 | SCV001232322 | likely benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2023-10-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004559893 | SCV002609874 | uncertain significance | Dyskeratosis congenita | 2018-01-22 | criteria provided, single submitter | clinical testing | The p.R1084Q variant (also known as c.3251G>A), located in coding exon 15 of the TERT gene, results from a G to A substitution at nucleotide position 3251. The arginine at codon 1084 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004693570 | SCV005189385 | uncertain significance | not provided | criteria provided, single submitter | not provided |